Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced Dr. Stefanie Johns, who has agreed to join Hoth and serve as its Chief Scientific Officer, is scheduled to appear as a featured guest on One America News Network Tuesday, September 1, 2020 at 3:00pm ET.
Interested parties can find One America News Network on the following national providers: AT&T U-verse – 208 (SD) and 1208 (HD), CenturyLink PRISM – 208 (SD) and 1208 (HD), DirecTV – 347, GCI – 64 (SD) and 703 (HD), and Verizon FiOS – 116 (SD) and 616 (HD). Dr. Johns will talk about Hoth's recent announcement that it has licensed a real time, breath- based COVID-19 Mobile Testing Device.
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please visit https://ir.hoththerapeutics.com/.
